Evidence of mitigated calcification of the Mosaic versus Hancock Standard valve xenograft in the mitral position of young sheep  by Weber, Patricia A. et al.
E
T
E
H
y
P
Tvolving
echnologyvidence of mitigated calcification of the Mosaic versus
ancock Standard valve xenograft in the mitral position of
oung sheep
atricia A. Weber, DrPH,a Jérôme Jouan, MD,a Akira Matsunaga, MD,a Elena Pettenazzo, PhD,bhomas Joudinaud, MD,a Gaetano Thiene, MD, FRCP,b and Carlos M. G. Duran, MD, PhDa
O
c
e
e
fi
o
M
m
w
A
fi
r
a
R
t
S
M
fi
g
C
x
m
p
T ethern.
r
t
g n.
W
ETFrom the International Heart Institute of
Montana Foundation at Saint Patrick Hos-
pital and Health Sciences Center and The
University of Montana, Missoula, Mont,a
and the Institute of Pathological Anatomy,
University of Padua, Italy.b
This study was supported by an unrestricted
research grant from Medtronic, Inc.
Dr Duran reports lecture and consulting
fees from Medtronic. Dr Thiene reports lec-
ture fees from Medtronic.
Address for reprints: Carlos M. G. Duran,
MD, PhD, The International Heart Institute
of Montana Foundation, 500 W Broadway,
Suite 350, Missoula, MT 59802 (E-mail:
cduran@ihimontana.org).
J Thorac Cardiovasc Surg 2006;132:1137-43
0022-5223/$32.00
Copyright © 2006 by The American Asso-
ciation for Thoracic SurgeryS
doi:10.1016/j.jtcvs.2006.06.027
Tbjectives: Durability remains the main problem of all bioprosthetic valves, and
alcification is the major cause of failure. New tissue treatment processes are
xpected to reduce mineralization. A comparative animal study was undertaken to
valuate the behavior of a new-generation porcine bioprosthesis in contrast with a
rst-generation porcine bioprosthesis. The primary goal was to evaluate the efficacy
f -amino-oleic acid as an anticalcification treatment.
ethods: Seventeen Targhee sheep (aged 4.5-7 months) had a mitral valve replace-
ent with a Mosaic or Hancock Standard. The animals were followed up to 20
eeks (144.1  4.0 days vs 144.3  8.2 days) and then euthanized as scheduled.
fter gross examination, the explants were radiographed for the presence of calci-
cation. The central portions were preserved for histologic examination, and the
emainder of the sample was analyzed for quantitative calcium content by atomic
bsorption spectroscopy.
esults: Four Mosaic sheep were excluded because of perioperative surgical mor-
ality. The remaining 13 were enrolled in the study (9 Mosaic and 4 Hancock
tandard). The mean calcium content was 1.97  2.21 g/mg tissue weight for
osaic versus 8.36  4.12 g/mg for Hancock Standard valves (P  .01). Mild
brous tissue overgrowth and fibrinous lining were observed regardless the xeno-
raft type.
onclusions: The low level of calcification in the Mosaic versus Hancock Standard
enografts confirms the efficacy of -amino-oleic acid treatment in mitigating
ineralization. A longer durability is expected with the clinical use of the Mosaic
orcine valve.
 
he primary problem of all valve bioprostheses of xenogeneic origin, wh
porcine or pericardial, is tissue degeneration with dystrophic calcificatio1-3
Structural valve deterioration results in patient morbidity that necessitates
eoperation. Considerable effort over many years by the manufacturers of biopros-
hetic valves has been directed toward developing tissue treatment, combined with
lutaraldehyde fixation, to mitigate the detrimental effects of tissue calcificatio4-9
e report the results of a comparative study between the Mosaic and Hancocktandard valve xenografts (both from Medtronic Heart Valve Division, Santa Ana,
he Journal of Thoracic and Cardiovascular Surgery ● Volume 132, Number 5 1137
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ETalif) in a young sheep model as an accepted means of
valuating the effect of -amino-oleic acid for the mitiga-
ion of calcification in a circulatory model.
aterials and Methods
esign of the Study
osaic and Hancock Standard porcine mitral valve prostheses of
linical quality (25-mm annular diameter) were implanted in
oung Targhee sheep (4.5-7 months of age, approximately 25-45
g in body weight, and either neutered male or female). The order
f valve implantation was determined by random selection. The
alve to be implanted on a given day was unknown to the surgeon
nd the surgical team until the sheep was ready for implantation.
ccording to the Experimental Standard Organization guidelines
or in vivo preclinical valve testing,10 the valves were left in pla
or a minimum of 20 weeks.
All animals received humane care in accordance with the
rinciples of Laboratory Animal Care formulated by the Animal
elfare Act in the Guide for the Care and Use of Laboratory
nimals prepared by the Institute of Laboratory Animal Resources
nd published by the National Institutes of Heath (publication no.
5-23, revised 1996). The use of the animals for this study was
lso reviewed and approved by the Institutional Animal Care and
se Committee of the University of Montana.
urgical Technique
heep were evaluated for body temperature, heart rate, and respi-
atory health (lung sounds and respiratory secretions were
hecked). Blood was drawn for a complete blood count and serum
hemistry profile up to 1 month before surgery. All animals were
asted from food for 24 hours before surgery and from water for at
east 16 hours. All animals received ceftiofur sodium (3.0 mg/kg)
nd gentamicin (80 mg) by intramuscular injection at least 90
inutes before the initiation of cardiopulmonary bypass (CPB). In
ddition, 80 mg of ceftiofur sodium was added to the CPB prime
olution. All surgical procedures were performed by a single
urgeon with the same surgical team. A 14-gauge angiocatheter
as placed in the external jugular vein, and the animals were
remedicated with ketamine 1.0 mg/kg and atropine 0.03 mg/kg,
ollowed by propofol 4.0 mg/kg body weight. The sheep were
ndotracheally intubated, and artificial ventilation was achieved
ith a volume respirator (North American Drager, Telford, Pa)
upplemented with oxygen at 4 L/min. Anesthesia was maintained
ith isoflurane (1.5%-2.5%) and intermittent propofol. A left
horacotomy was performed through the fourth intercostal space.
eparin 300 U/kg was injected intravenously as a bolus in prep-
ration for CPB with a target activated clotting time of approxi-
ately 480 seconds. The descending aorta was cannulated with a
2F cannula. The right atrium was cannulated with a 29F double-
tage venous cannula. The cardioplegia cannula was placed, and
PB was established. Cardioplegia (4:1 blood) was administered,
Abbreviations and Acronyms
CPB cardiopulmonary bypassnd the heart was arrested. An oblique left atriotomy was per- t
138 The Journal of Thoracic and Cardiovascular Surgery ● Novormed starting at the roof of the atrium and continuing through the
eft appendage to the atrioventricular groove. Duran sizers
Medtronic, Inc, Minneapolis, Minn) were used to determine the
ize of the mitral valve annulus. Eleven to 13 2-0 pledgeted and
ouble-edged Ethibond (Ethicon, Inc, Somerville, NJ) sutures
ere placed all around the annulus. Sutures were then passed
hrough the sewing ring of the bioprosthesis so that the largest
ntercommissural portion corresponded to the left outflow tract,
hus assuring that each valve was placed in each animal in an
dentical position. The native leaflets and chordal structures were
reserved in each case. The prosthesis was descended and tied at
he annulus level. The left atriotomy was closed, and the heart was
efibrillated as needed. Lidocaine and magnesium were adminis-
ered if necessary. The sheep were weaned from CPB, and hemo-
ynamics were allowed to stabilize before epicardial echocardiog-
aphy. Protamine sulfate was administered intravenously. The
orta was decannulated, and hemostasis was checked. A chest tube
as placed, and bupivacaine was administered along the third,
ourth, and fifth intercostal nerves during closing. The muscles and
kin were closed in 3 layers with 2-0 Vicryl (Ethicon) running
utures. After a minimum of 5 days of postoperative care, the
heep were returned to the farm.
xplant Analysis
n the scheduled date of termination, sheep were anesthetized as
escribed for surgery. After all hemodynamic data were recorded
s described previously, the sheep were euthanized, the gross
athology of the heart and lungs was observed, and any abnor-
alities were noted. The hearts were excised, the mitral valves
ere dissected from the heart, and photographs were taken of both
he atrial and ventricular aspects. The condition of the valve was
cored by the surgeon on a scale of 0 to 4 (with 0 representing the
bsence of a problem), for the following parameters: stiffness,
eaflet insertion dehiscence, tissue overgrowth, thrombi, cuspal
ematomas, calcifications, vegetations, fenestration or tears,
tretching, abrasion, suture interactions, and structural relation-
hips. The valves were placed in 10% neutral buffered formalin.
adiography
eaflets were removed from the stent and labeled anterior, left, and
ight according to the orientation of the valve in situ. Radiographs
ere taken with mammography equipment (LORAD M III; Bed-
ord, Mass). Calcification was scored on a scale of 0 to 4 for each
eaflet: 1, pinpoint single; 2, single more than 2 mm or multiple
inpoint; 3, multiple more than 2 mm; and 4, massive calcification.
he overall mean score of the 3 leaflets was calculated.
istology
he fixed samples were processed by cutting a 2- to 3-mm-wide
adial section through the middle of each cusp along with the
ssociated segment of sinus wall followed by dehydration and
mbedding in PolyFin wax (Polysciences, Inc, Warrington, Pa).
he samples were sectioned at 5 m and collected on SuperFrost
icroscope slides (Fisher Scientific, Hampton, NH). All sections
ere stained with hematoxylin and eosin for general tissue mor-
hology, Heidenhain trichrome for connective tissue, and Von
ossa for the presence of calcification. The thickness of fibrousissue overgrowth was measured with a micrometer.
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ETuantitative Calcium Analysis
fter the histology section was removed from each cusp, the
emainders of each leaflet, including the aortic wall and base, were
ll placed into an appropriately labeled container and shipped to
AMSA (Northwood, Ohio) for analysis by inductively coupled
lasma mass spectrometry. Calcium content was expressed as
icrograms per milligram of tissue (sample weight).
tatistical Analysis
ll numeric data are presented as mean  SD. All statistical
nalyses were performed with SPSS (SPSS, Inc, Chicago, Ill).
ifferences between groups were determined by unpaired Student
tests for the radiography score. Normal probability plots showed
hat the quantitative calcium data had a nonnormal distribution.
valuation of the quantitative calcium data found a single outlier
n each valve group (Mosaic #330 cusp A and Hancock #311 cusp
). The Wilcoxon 2-sample test was used to compare the quanti-
ative calcium data from the 2 valve groups.
esults
urvival Data
eventeen young sheep (average weight, 37.2  6.0 kg;
verage age, 6.2  1.0 months) underwent a mitral valve
eplacement with a Mosaic or a Hancock Standard valve.
our sheep that received a Mosaic valve were excluded
ecause of perioperative surgical mortality. Two animals
ied on the operating table of arrhythmia: one before can-
ulation and the other after bypass. Two sheep died after
urgery: one at day 4 and one at day 5 of unknown causes.
t necropsy, there was no hemothorax, and the valves were
ell seated without paravalvular leaks or thrombus. The
emaining 13 were enrolled in the study and included 9
osaic and 4 Hancock Standard valves. All Mosaic and
ancock Standard sheep reached the planned sacrifice time
f at least 140 days, for an average survival of 144.1  4.0
ays and 144.3  8.2 days, respectively.
chocardiographic Evaluation
t implantation, all valves were competent, gradients
ere normal, and mitral regurgitation was absent. Not all
chocardiographic data at sacrifice were available, but
itral regurgitation, if present, was trivial for both valve
ypes.
acroscopic Evaluation
o valve showed evidence of coarse calcification or vege-
ation, leaflet tears, stenotic pannus, commissural dehis-
ence, paravalvular leak, or suture looping (average score:
osaic, 0.11  0.32; Hancock, 0.14  0.35). Tiny cuspal
ematomas were observed on 2 of the Hancock Standard
alves. Small thrombus vegetations (2 mm) were evident
n 5 of 9 Mosaic valves and 2 of 4 Hancock Standard
alves. Calcific nodules were seen by the naked eye in only
 Hancock Standard (Figure 1, a). c
The Journal of Thoracicadiograph Data
he mean radiograph score for the Mosaic valves was 1.15
0.51 versus 2.58  0.51 for the Hancock Standard (P 
01). Values for individual valves are shown in Table 
he Hancock Standard, calcification was focused in the
ortic wall and commissures (Figures 1, b, and 2, a, and
able 1) and occasionally at the base of the cusps (Fig
, and Table 1). Mineralization of the Mosaic valve sp
he cusps and, when present, involved the aortic wall 
re 4, a, and Table 1). Three of 9 Mosaic valves ha
etectable calcification.
istologic Analysis
egardless of the valve type, the endothelial lining appeared
ostly detached, and small thrombus vegetations were fre-
uently seen on the atrial side of the cusps. The Hancock
tandard xenograft showed a loose spongiosa and flattened
ollagen fibers. In contrast, the Mosaic xenograft showed a
ostly preserved ground substance and wavy collagen in
he fibrosa (Figure 4, b). Intracuspal hemorrhage was 
ccasional finding in both types of valves.
Host fibrous tissue overgrowth was observed mostly on
he atrial surface, and it covered the basal part of 1 or more
igure 1. Hancock Standard explant in place in the mitral posi-
ion for 142 days (calcium content: 10.87 g/mg tissue weight). a,
ross view of the cusps: the arrow indicates a calcific nodule in
he left cusp close to the commissure. b, Radiograph: calcific
eposits are mainly located at the commissures and aortic wall
mean score, 2.33). A, Anterior; L, left; R, right.usps. No difference in thickness was found between the
and Cardiovascular Surgery ● Volume 132, Number 5 1139
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1
ETosaic and Hancock Standard (493  184 m and 400 
51 m, respectively).
In the aortic wall, calcium deposits most often occurred
lose to the commissures (Figure 2, b). A node of calci
ation was observed only in the free margin of a Hancock
tandard cusp. When the base of the Hancock Standard cusp
as mineralized, the muscle shelves appeared to be
olved (Figure 3, b).
tomic Absorption Spectroscopy
he mean calcium content for the Mosaic valve was 1.97 
.21 g/mg tissue weight, compared with 8.36  4.12
g/mg for the Hancock Standard group (P  .0001; Figure
). Two data points were removed from the analysis o
asis of a statistical test for outliers: the value for cusp A
rom sheep 330 (Mosaic) and that for cusp R from sheep
11 (Hancock).
iscussion
ystrophic calcification of glutaraldehyde-treated cardiac
alve bioprostheses remains the main threat of long-term
urability.1-3 Major efforts have been made to deve
ifferent anticalcification strategies to prevent or mitigate
he calcification process and improve long-term
urability.4-10
Postfixation treatments that neutralize the toxicity of the
ldehyde group residuals from the cross-linking have been
sed as possible anticalcification strategies.11,12 In this re-
pect, the use of -amino-oleic acid as a successful antical-
ification agent for glutaraldehyde cross-linked tissue
alves was first reported in a young sheep model in 1992 by
ott and colleagues,5 and a refined technique was describ
able 1. Summary of major findings for individual cases
heep no.
Time in place
(d)
Radiograph scor
(mean A, L, R)
osaic
309 140 0.33
315 141 1.7
316 140 2
321 149 0
314 148 2.7
323 148 1
326 148 0
330 141 0
334 142 2.7
ancock Standard
311 142 2.3
317 153 2.7
333 148 2.7
338 134 2.7
, Anterior; L, left; R, right. *Average of 2 leaflets.e Calcium content
(mean A, L, R; g/mg tissue) Site of calcification
0.08 Aortic wall
2.4 Aortic wall
3.6 Aortic wall
0.04 None
3.6 Aortic wall
0.15 Aortic wall
0.03 None
2.71* None
5.4 Aortic wall
10.87* Aortic wall and cusps
10.5 Aortic wall
5.9 Aortic wall and cusps
7.0 Aortic wall and cuspsy the same group in 1997.13 Chen and colleagues6,14 K
140 The Journal of Thoracic and Cardiovascular Surgery ● Nove
igure 2. Hancock Standard explant in place in the mitral posi-
ion for 134 days (calcium content: 7.00 g/mg tissue weight). a,
adiograph: calcification mostly involves the aortic wall (mean
core, 2.66). b, Histology of the aortic wall of the left cusp: note
he calcific deposit involving the aortic tunica media (stain, Von
ossa; original magnification, 12). A, Anterior; L, left; R, right.
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EThowed that the mechanism of -amino-oleic acid as an
nticalcification agent may be multifactorial; besides bond-
ng the free aldehyde groups, it greatly reduces calcium ion
nflux into glutaraldehyde-fixed bioprosthetic tissue, thus
etarding the kinetics of crystalline calcium phosphate for-
ation. A comparative study in the rat subcutaneous model
f 5 commercially available bioprosthetic valves demon-
trated the efficacy of -amino-oleic acid (Medtronic Mo-
aic and Freestyle) and sodium dodecyl sulphate (Medtronic
ancock II) for the inhibition of tissue calcification com-
ared with no special treatment (St Jude Toronto SPV; St
ude Medical, Inc, St Paul, Minn) or treatment with tolu-
dine blue (Medtronic Intact).15 In a clinical report b
erosa and associates16 that compared the Hancock Sta-
ard with the Hancock II bioprosthesis (which is fixed under
igure 3. Hancock Standard explant in place in the mitral posi-
ion for 148 days (calcium content: 5.90 g/mg tissue weight). a,
adiograph: the calcific deposits also involve the base of the
eaflets (mean score, 2.66). b, Histologic panoramic view of the
eft cusp showing a large spot of calcium deposit on the muscle
helf of the leaflet (stain, Von Kossa; original magnification, 3).
, Anterior; L, left; R, right.ow pressure and treated with sodium dodecyl sulphate), the p
The Journal of Thoracicctuarial freedom from structural valve deterioration at 15
ears was 50% in patients with the Hancock Standard
ioprosthesis and 88% in those with the Hancock II
ioprosthesis.
The Mosaic valve is a third-generation stented porcine
ioprosthesis. Its improved design includes zero-pressure
ifferential fixation of the glutaraldehyde-treated tissue, the
ddition of an -amino-oleic acid postfixation treatment to
etard mineralization, and the use of a flexible polymer
ow-profile stent. The results of the first clinical trials
howed very satisfactory mid-term performance. In a study
y Fradet and associates,17 freedom from structural valv
eterioration was found to be 100% at 7 years in both the
itral and the aortic positions. The multicenter European
xperience reported by Eichinger and colleagues18 endorsed
hese findings, reporting freedom from structural valve de-
erioration in the aortic position at 5 years and in the mitral
igure 4. Mosaic explant in place in the mitral position for 140
ays (calcium content: 0.08 g/mg tissue weight). a, Radiograph
ith pinpoint calcification (arrow) at 1 commissure (mean score,
.33). b, Histologic view of the left cusp showing the integrity of
he cusp tissue, particularly the spongiosa (stain, Heidenhain
richrome; original magnification, 8).osition at 4 years of 98.8% and 100%, respectively.
and Cardiovascular Surgery ● Volume 132, Number 5 1141
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1
ETThe young, growing sheep is a well-known model for
ccelerated calcification of bioprosthetic valves, and it is
ell accepted for the comparison of anticalcification treat-
ents in circulatory implants.19,20 In our experiment, th
alcification that regularly occurred in the Hancock Stan-
ard was mostly confined to the commissures, aortic wall,
nd muscle shelves, thus confirming that the young sheep
odel was effective in the 20-week span.10
The Mosaic porcine valves showed a sharp difference in
alcification in radiographic (mean score of 1.15  0.51 for
osaic vs 2.58  0.51 for Hancock Standard) and atomic
bsorption spectroscopy (mean calcium content of 1.97 
.21 g/mg tissue weight for Mosaic vs 8.36  4.12 g/mg
issue weight for Hancock Standard) measurements. In this
egard, it is quite significant that 3 cases with the Mosaic
ioprosthesis showed no evidence of calcification 20 weeks
fter implantation.
Our results support the findings of an earlier study by
uarte and colleagues,21 who reported that tissue calcific-
ion was significantly reduced in Mosaic valves placed in
he mitral position of juvenile sheep when compared with
ancock Standard valves. In Duarte and associates’ study,
alves were radiographed in toto. Although this method
akes it easier to view cusp calcification, it is impossible to
valuate calcification of the commissures and base of the
alve because of the presence of the stent. In our experi-
ent, valves were dissected from the stent before radiogra-
hy, thus allowing the precise localization of all radiopaque
alcium deposits. The reported radiograph score of calcifi-
ation is representative of the total valve. Of note is that no
alcification was localized in the cusps of the Mosaic
alves, whereas evidence of cusp calcification was seen in
he Hancock Standard valves. The absence of calcific de-
osits in the cusps of the Mosaic valves confirms the more
ffective anticalcification influence of -amino-oleic acid
igure 5. Calcium content by atomic absorption spectroscopy:
.97 2.21 g/mg tissue weight for the Mosaic versus 8.36 4.12
g/mg tissue weight for the Hancock Standard (mean  SD; *P
.01).n cusp tissue than on the aortic wall.6,14
142 The Journal of Thoracic and Cardiovascular Surgery ● NovIn Duarte and associates’ study,21 in which cuspal ca-
ium levels were analyzed separately from those of the
ortic wall, the mineralization was 9.6 13.9 g/mg for the
osaic versus 130.8 43.2 g/mg dry weight for Hancock
tandard valves for cusps and 60.8  43.1 g/mg for the
osaic versus 149.4  43.6 g/mg dry weight for the
ancock Standard in the aortic wall. The levels of quanti-
ative calcium that we detected were much lower than those
eported in the Duarte study, a finding that may be explained
y the fact that the average age of the sheep at implantation
n the Duarte study was 3 to 5 months, versus 4.5 to 7
onths in our experiment. In contrast with the Duarte study,
n which a sharp difference of survival was present in the
ancock Standard versus the Mosaic group (82.3 35 days
s 139.9  4 days, respectively), our experiment showed
omparable survival between the 2 groups (144.3  8.2
ays vs 144.1  4.0 days). The difference in survival is
ost likely attributable to increased calcification in the
ounger sheep resulting in excessive calcification and valve
tenosis. This information is important in the planning of
ny study designed to distinguish anticalcification treat-
ents of bioprosthetic valves.
Our results are also supported by a study by Flameng and
ssociates22 that evaluated the Medtronic Mosaic val
long with the Epic (St Jude Medical, St Paul, Minn)
ancock II, and Labcor (Sulzer Carbomedics, Austin, Tex)
alves in juvenile sheep for 3 and 6 months. Although this
tudy did not compare the Hancock Standard valve and
alves were implanted in the pulmonary position, thus re-
ulting in less calcification, the Medtronic Mosaic valve
learly had significantly less calcium content, as measured
y atomic absorption spectroscopy, than the Hancock II.
The limitations of our study include the small sample
ize in the control group and the fact that the study design
id not consider differentiation between cusp and aortic
all calcification by quantitative methods, although our
ethod of radiograph analysis allowed superior localization
f calcification.
In conclusion, the low level of calcification in the Mosaic
ioprosthesis (measured both by radiography and by atomic
bsorption spectroscopy) confirms the efficacy of -amino-
leic acid treatment in retarding mineralization. A longer
urability is expected with the clinical use of the Mosaic
orcine valve.
We express our gratitude for the skillful collaboration given
uring this investigation by Emily Dove, Leslie Trail, Billi Bill-
ngton, Holly Meskimen, Matthew Hiro, Mauro Pagetta, and Ag-
stino Leorin. The authors also thank Katherine Johnson and Jorge
olis, MD, for their assistance with the statistical analysis.
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